Abbott Laboratories On Track for Largest Percent Decrease Since October 2023 — Data Talk
Abbott Laboratories (ABT) is currently at $113.79, down $5.06 or 4.26%
--Would be lowest close since Feb. 15, 2024, when it closed at $113.64
--On pace for largest percent decrease since Oct. 11, 2023, when it fell 5.04%
--Currently down four of the past five days
--Currently down three consecutive days; down 5.77% over this period
--Worst three day stretch since the three days ending Oct. 13, 2023, when it fell 6.86%
--Down 4.09% month-to-date
--Up 3.38% year-to-date
--Down 19.56% from its all-time closing high of $141.46 on Dec. 27, 2021
--Up 17.3% from 52 weeks ago (March 17, 2023), when it closed at $97.01
--Down 5.93% from its 52-week closing high of $120.96 on March 8, 2024
--Up 26.17% from its 52-week closing low of $90.19 on Oct. 12, 2023
--Traded as low as $112.26; lowest intraday level since Feb. 14, 2024, when it hit $111.12
--Down 5.54% at today's intraday low; largest intraday percent decrease since Oct. 11, 2023, when it fell as much as 5.65%
--Fourth worst performer in the S&P 500 today
All data as of 10:14:33 AM ET
Source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
March 15, 2024 10:33 ET (14:33 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
When Will the Fed Start Cutting Interest Rates?
-
What’s the Difference Between the CPI and PCE Indexes?
-
Powell Unfazed By Sticky Inflation, but Rate Cuts Are Far Off
-
After Earnings, Is Microsoft Stock a Buy, a Sell, or Fairly Valued?
-
Best- and Worst-Performing Stocks of April 2024
-
Magnificent 7 Stocks Earnings Updates: AI Remains the Focus
-
Small-Cap and Value Stocks Are Undervalued
-
Why We Expect the Job Market’s Slowdown to Renew in 2024
-
Look Inside Berkshire Hathaway’s Portfolio Before Its Annual Meeting
-
How to Invest Like Warren Buffett
-
Cognizant Earnings: Improved Profitability Buttresses Results as Customer Spending Remains Muted
-
10 Top-Performing Dividend Stocks of the Month
-
Marathon Petroleum Earnings: No Change to Competitive Position, but Shares Look Expensive
-
Charlie Munger and How Not to Invest
-
After Earnings, Is AT&T Stock a Buy, a Sell, or Fairly Valued?
-
Mastercard Earnings: A Stable Environment Highlights the Firm’s Strengths